scorecardresearch
Wednesday, August 27, 2025
TopicAdar Poonawalla

Topic: Adar Poonawalla

What Poonawalla’s Rs 1,000 crore deal means for Dharma—more freedom, big-budget productions

Karan Johar recently spoke about exorbitant star fees and rising entourage costs, which were affecting the industry and production of films.

Karan Johar’s studio sells 50% stake worth 10 bn rupees to vaccine maker Adar Poonawalla

SII CEO will buy stake through his production company, Serene Productions -- another major investment outside pharma sector after picking up 20% of social media platform Wakau Interactive in 2021.

A piece of bone, hair sent for advanced DNA test belong to Shraddha Walkar, say police

A superior mitochondrial DNA test is run when nuclear DNA cannot be extracted from samples or when they are highly decomposed.

Rising Covid cases in China concerning but India need not panic, says SII CEO Aadar Poonawalla

The Serum Institute CEO’s tweet came a day after the Health Ministry urged states to ramp up the genome sequencing of positive samples to keep track of newer Covid variants.

Production of HPV vaccine for cervical cancer to start in 1st quarter of 2023: Adar Poonawala

The CEO said that the production of India's 1st indigenously developed quadrivalent Human Papillomavirus (HPV) vaccine will supply 1 to 2 million doses per month to the govt.

ThePrint’s Editor-in-Chief Shekhar Gupta recognised with ‘Lifetime Contribution to Media’ award

Thirteen other noted personalities including Serum Institute of India CEO Adar Poonawalla and Tata Sons Chairman N Chandrasekaran were also awarded under various categories by AIMA.

Didn’t suit global narrative that Indian firm could deliver quality, says SII’s Poonawalla

CEO of world’s largest vaccine maker says India is better equipped to deal with pandemics now, adds a global treaty is important to allow resource-sharing across borders.

Serum Institute plans to launch Covid vaccine for children in next 6 months

Speaking at a conference Tuesday, Serum Institute of India's CEO Adar Poonawalla said the Covovax vaccine is under trial & would offer protection to children as young as 3 years.

Modi on Time 100 list for ‘Hindu nationalism, eroding Muslims’ rights, mishandling Covid’

Modi is one of three Indians on Time’s 100 Most Influential list. The only other Indian politician on the list is West Bengal Chief Minister Mamata Banerjee.

Biocon partners SII to make vaccine, drug manufacturing accessible to developing nations

Under the deal, Biocon Biologics Ltd (BBL) will offer approximately 15% stake to Serum Institute Life Sciences at a post-money valuation of about Rs 35,000 crore.

On Camera

Sergio Gor as US envoy raises red flags. Delhi must read the signal, be optimistic

Delhi must see opportunity in the new envoy, to be prepared for hurdles, yet be forward-looking and free of preconceived notions that could spoil any chances of a breakthrough.

New insolvency frameworks to shorter timelines, how 2025 amendment bill proposes to transform IBC

New bill aims to fix key issues with IBC 2016, including delays & patchy implementation, and protect creditors, with window for genuine promoters to retain control of their companies.

‘Not troop size or weapons but tech matters, need to prepare for long conflicts’—Rajnath Singh

At Ran Samvad seminar, defence minister spoke about reasons behind success of Op Sindoor, explained how warfare changed in real time & called for upgradation of tech & cyber infra.

That Oval Office picture for ages deserves closer Indian reading, with a geopolitical lens

Putin sees this as a victory. Europeans have decided to deal with Trump on his terms for the sake of the larger Western alliance. We look at the lessons for us in India.